1-10 of 10
Ronald B. Gartenhaus
Close
Sort by
Journal Articles

Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase

James J. Steinhardt, Raymond J. Peroutka, Krystyna Mazan-Mamczarz, Qing Chen, Simone Houng, Carol Robles, Rolf N. Barth, Joseph DuBose, Brandon Bruns, Ronald Tesoriero, Deborah Stein, Raymond Fang, Nader Hanna, Jason Pasley, Carlos Rodriguez, Mark D. Kligman, Matthew Bradley, Joseph Rabin, Stacy Shackelford, Bojie Dai, Ari L. Landon, Thomas Scalea, Ferenc Livak, Ronald B. Gartenhaus
Journal: Blood
Blood (2014) 124 (25): 3758–3767.
https://doi.org/10.1182/blood-2014-07-589689
Published: 2014
Includes: Supplemental data
Journal Articles

The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies

Duan Wang, Linhao Li, Hui Yang, Stephen S. Ferguson, Maria R. Baer, Ronald B. Gartenhaus, Hongbing Wang
Journal: Blood
Blood (2013) 121 (2): 329–338.
https://doi.org/10.1182/blood-2012-06-436691
Published: 2013
Includes: Supplemental data
Journal Articles

The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma

Savita Bhalla, Andrew M. Evens, Bojie Dai, Sheila Prachand, Leo I. Gordon, Ronald B. Gartenhaus
Journal: Blood
Blood (2011) 118 (4): 1052–1061.
https://doi.org/10.1182/blood-2011-03-340109
Published: 2011
Includes: Supplemental data
Journal Articles

ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes

Krystyna Mazan-Mamczarz, Patrick R. Hagner, Yongqing Zhang, Bojie Dai, Elin Lehrmann, Kevin G. Becker, Jack D. Keene, Myriam Gorospe, Zhenqui Liu, Ronald B. Gartenhaus
Journal: Blood
Blood (2011) 117 (8): 2441–2450.
https://doi.org/10.1182/blood-2010-09-310987
Published: 2011
Includes: Supplemental data
Journal Articles

Targeting the translational machinery as a novel treatment strategy for hematologic malignancies

Patrick R. Hagner, Abraham Schneider, Ronald B. Gartenhaus
Journal: Blood
Blood (2010) 115 (11): 2127–2135.
https://doi.org/10.1182/blood-2009-09-220020
Published: 2010
Journal Articles

Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction

Patrick R. Hagner, Krystyna Mazan-Mamczarz, Bojie Dai, Sharon Corl, X. Frank Zhao, Ronald B. Gartenhaus
Journal: Blood
Blood (2009) 113 (22): 5526–5535.
https://doi.org/10.1182/blood-2008-11-191783
Published: 2009
Includes: Supplemental data
Journal Articles

Phosphorylation of the MCT-1 Oncogene Protein by p42/44 MAPK Is Required for Transformation.

Suvobroto Nandi, PhD, Line S. Reinert, MS, Ali Hachem, MD, Ronald B. Gartenhaus, MD
Journal: Blood
Blood (2005) 106 (11): 2624.
https://doi.org/10.1182/blood.V106.11.2624.2624
Published: 2005
Journal Articles

Oncogenes as molecular targets in lymphoma

Ali Hachem, Ronald B. Gartenhaus
Journal: Blood
Blood (2005) 106 (6): 1911–1923.
https://doi.org/10.1182/blood-2004-12-4621
Published: 2005
Journal Articles

Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells

Andrew M. Evens, Philip Lecane, Darren Magda, Sheila Prachand, Seema Singhal, Jeff Nelson, Richard A. Miller, Ronald B. Gartenhaus, Leo I. Gordon
Journal: Blood
Blood (2005) 105 (3): 1265–1273.
https://doi.org/10.1182/blood-2004-03-0964
Published: 2005
Journal Articles

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies

Bo Shi, Hsin-Ling Hsu, Andy M. Evens, Leo I. Gordon, Ronald B. Gartenhaus
Journal: Blood
Blood (2003) 102 (1): 297–302.
https://doi.org/10.1182/blood-2002-11-3486
Published: 2003